-
公开(公告)号:US12037414B2
公开(公告)日:2024-07-16
申请号:US16813380
申请日:2020-03-09
发明人: Scott Duncan , D. Travis Wilson
CPC分类号: C07K5/1019 , C07K1/02 , C07K1/04
摘要: The present technology provides methods of generating the peptides, and pharmaceutically acceptable salts of the peptides and intermediates thereof. In some embodiments, the peptide is D-Arg-2′6′-Dmt-Lys-Phe-NH2.
-
公开(公告)号:US12018047B2
公开(公告)日:2024-06-25
申请号:US17282855
申请日:2019-11-12
发明人: Joo Young Lee , Chang Suk Lee , Jin Woo Jeon , Jun Ok Moon , Jin Seung Park
IPC分类号: C07K1/30 , B01J23/02 , C07C319/12 , C07C319/26 , C07K1/02
CPC分类号: C07K1/306 , B01J23/02 , C07C319/12 , C07C319/26 , C07K1/02 , C07B2200/13
摘要: Provided is a method of preparing an N-acetyl dipeptide and an N-acetyl amino acid, the method including producing the N-acetyl dipeptide and the N-acetyl amino acid by reaction of an amino acid with acetic anhydride or acetyl chloride.
-
公开(公告)号:US20240156126A1
公开(公告)日:2024-05-16
申请号:US18284569
申请日:2022-03-24
CPC分类号: A23J1/205 , A23C19/053 , A23C21/00 , A23J3/08 , B01D61/145 , B01D61/147 , B01D61/149 , B01D69/02 , C07K1/026 , A23C2210/206 , B01D2311/06 , B01D2315/16 , B01D2325/0283 , B01D2325/20
摘要: A production method for an MP whey is provided, that enables preparation of both of a high GMP-content composition and a usable MP whey from an ordinary MP whey. The problems can be solved by a production method for a glycomacropeptide-containing composition, that includes a step of acquiring a solution containing glycomacropeptide, that includes a glycomacropeptide content of 10% by weight or higher in the protein total amount by condensing and/or applying diafiltration to a microparticulated whey solution.
-
公开(公告)号:US11787837B2
公开(公告)日:2023-10-17
申请号:US16346560
申请日:2017-11-07
申请人: Novo Nordisk A/S
IPC分类号: A61K47/60 , C07C309/42 , C07C311/29 , C07C317/22 , C08L71/02 , C07K1/02 , C07K1/113 , C07K1/107 , C07K14/605 , C07K14/62 , C08L71/00 , A61K47/54
CPC分类号: C07K1/1077 , A61K47/542 , A61K47/60 , C07C309/42 , C07C311/29 , C07C317/22 , C07K1/023 , C07K14/605 , C07K14/62 , C08L71/00 , C08L71/02 , C07C2601/14 , C08L2203/02
摘要: The present invention relates to a novel acylating agent, a method for its preparation, and a method of using it for acylating one or more amino groups of an amino acid, a peptide, or a protein. The novel acylating agent may be a compound which comprises a structural element —HN—(CH2)2-(O—((CH2)2)k-O—(CH2)n-CO—, wherein k is an integer in the range of 1-10, and n is an integer in the range of 1-2, being esterified at its —CO-end to the hydroxy group of 3,5-dichloro-2-hydroxy-benzenesulfonic acid (3,5-DC-2-HBSA). This novel acylating agent has an improved stability. Using this agent the acylation process is improved as regards robustness, as well as improving yield and overall production economy. The novel acylating agent is useful for acylating pharmaceutical peptides and proteins such as GLP-1, insulin, pYY, and amylin. The invention also relates to a number of novel GLP-1 precursor peptides and derivatives in which the two N-terminal amino acids have been deleted.
-
公开(公告)号:US11779548B2
公开(公告)日:2023-10-10
申请号:US16871902
申请日:2020-05-11
发明人: Jie Li , Zilei Liu , Suhua Li , Peng Wu , K. Barry Sharpless
IPC分类号: A61K31/05 , A61K31/136 , C07C305/26 , C07K1/113 , C07K1/02 , A61K51/04 , A61K38/31 , A61K31/7048 , A61K31/70 , A61K31/655 , A61K31/65 , A61K31/56 , A61K31/5513 , A61K31/53 , A61K31/515 , A61K31/505 , A61K31/485 , A61K31/4745 , A61K31/473 , A61K31/4709 , A61K31/47 , A61K31/439 , A61K31/4353 , A61K31/4245 , A61K31/4168 , A61K31/407 , A61K31/4045 , A61K31/40 , A61K31/397 , A61K31/198 , A61K31/197 , A61K31/14 , C07K2/00 , C07D295/26 , C07D295/185 , C07D295/088 , C07D277/82 , A61K47/54 , C40B30/06 , C40B30/04 , C40B50/08 , C12N5/09 , C40B40/04
CPC分类号: A61K31/05 , A61K31/136 , A61K31/14 , A61K31/197 , A61K31/198 , A61K31/397 , A61K31/40 , A61K31/407 , A61K31/4045 , A61K31/4168 , A61K31/4245 , A61K31/439 , A61K31/4353 , A61K31/47 , A61K31/473 , A61K31/4709 , A61K31/4745 , A61K31/485 , A61K31/505 , A61K31/515 , A61K31/53 , A61K31/5513 , A61K31/56 , A61K31/65 , A61K31/655 , A61K31/70 , A61K31/7048 , A61K38/31 , A61K47/54 , A61K51/0497 , C07C305/26 , C07D277/82 , C07D295/088 , C07D295/185 , C07D295/26 , C07K1/02 , C07K1/1136 , C07K2/00 , C40B30/06 , C07C2601/14 , C07C2603/18 , C12N5/0693 , C12N2503/02 , C40B30/04 , C40B40/04 , C40B50/08 , G01N2500/00
摘要: A high-throughput screening methods for identifying candidate anticancer medicinal agents is described herein. The candidate anticancer medicinal agents are arylfluorosulfate compounds derived from phenolic compounds. The method involves in situ generation of the arylfluorosulfate compounds in multi-well plates by reaction of phenolic compounds in DMSO with a saturated solution of SO2F2 dissolved in a solvent such as acetonitrile, in the presence of an organic base, followed by reaction of generated fluoride ion with trimethylsilanol to form volatile trimethylsilyl fluoride. Solvents, organic base, and silyl compounds are then removed, in vacuo, to afford the arylfluorosulfate compounds suitable for biological screening in cancer cell lines without further purification.
-
公开(公告)号:US11702444B2
公开(公告)日:2023-07-18
申请号:US17984642
申请日:2022-11-10
发明人: Zhengzhi Wu , Bohua Long , Limin Li , Zhiyue Li , Zhanyan Liu
摘要: A preparation method of a novel natural bioactive peptide Tubulysin U includes: dissolving a compound 2 in trifluoroacetic acid, heating under reflux to prepare an intermediate, reacting with a compound 3 and N,N-diisopropylethylamine to obtain a product, reacting the product with 2, 6-dimethylpyridine and tert-butyldimethylsilyl trifluoromethanesulfonate, adding sodium hydroxide after the reaction to prepare an intermediate acid, reacting the intermediate acid with a compound 6, HATU and N,N-diisopropylethylamine to obtain a product, adding triphenylphosphine to prepare an intermediate amine, adding a compound 8 and HATU to react, adding ammonium fluoride to prepare a first intermediate, adding sodium hydroxide to the first intermediate to prepare a second intermediate, adding acetic anhydride to the second intermediate to prepare a third intermediate, adding trifluoroacetic acid to the third intermediate to prepare a fourth intermediate, and adding formaldehyde and sodium cyanoborohydride to the fourth intermediate to react, thereby obtaining a target product.
-
公开(公告)号:US20230047729A1
公开(公告)日:2023-02-16
申请号:US17963739
申请日:2022-10-11
申请人: DAEBONG LS CO., LTD.
发明人: Eun Ju PARK , Eun Teak KIM , Jin Oh PARK
摘要: Proposed is a novel method for preparing liraglutide by means of an ionic liquid and a eutectic solvent, which are environment-friendly solvents. More specifically, the method is characterized in that fractionated peptide 1 represented by the following formula (1) and fractionated peptide 2 represented by the following formula (2) are subjected to a coupling reaction in the presence of an ionic liquid or a eutectic solvent. In preparing GLP-1 analogues such as liraglutide, the present method increases reactivity when producing liraglutide, which is an unprocessed reactant, by using an ionic liquid and a eutectic solvent as environment-friendly solvents instead of using organic solvents. Accordingly, through a relatively short and simple purification process, the present method has advantages of reducing the formation of related substances, improving purity, improving yields, shortening reaction times, reducing production cost, and lowering the manufacturing cost.
-
公开(公告)号:US20220411794A1
公开(公告)日:2022-12-29
申请号:US17771790
申请日:2020-10-23
申请人: Universitaet Wien
发明人: Bojan ZAGROVIC , Anton POLYANSKY
IPC分类号: C12N15/113 , C07K1/02 , C07K16/32
摘要: A composition comprising a protein and at least one single-stranded linear RNA oligonucleotide with an unfolded tertiary structure, which is characterized by: a) a relative content of each of the nucleotides A, C, U, and G, which is the number of each of the nucleotides per total nucleotide number in the oligonucleotide, which relative content is the same ±10% (number of nucleotides per total nucleotide number) as compared to the relative content of the respective nucleotide in a reference; and/or b) a relative content of at least 50% (number of nucleotides per total nucleotide number) of one type of nucleotide selected from the group consisting of nucleotides A, C, U, and G, which exhibits the highest relative content (number of each of the nucleotides per total nucleotide number) in a reference; wherein the reference consists of a native mRNA or a set of different RNA sequences that covers all RNA sequences allowed by the universal genetic code, each encoding an amino acid sequence of at least three amino acids within a p re-determined aggregation-prone target region of said protein, wherein the oligonucleotide has a length which is the same length as the reference, or longer.
-
公开(公告)号:US11512108B2
公开(公告)日:2022-11-29
申请号:US17047464
申请日:2019-04-25
IPC分类号: C07K1/08 , C07K1/00 , C07C231/02 , C07K1/02
摘要: Provided is a novel method whereby an amide compound can be produced by highly stereoselectively and efficiently performing amidation between a plurality of amino acids and/or peptides. A compound of general formula (3) is synthesized by forming an amide bond between the carboxyl group on the right side of general formula (1) in a compound represented thereby and the amino group on the left side of general formula (2) in a compound represented thereby, in the presence of a Lewis acid catalyst and a silylating agent [in formulae (1), (2) and (3), each symbol has the same meaning as defined in claims].
-
公开(公告)号:US20220332754A1
公开(公告)日:2022-10-20
申请号:US17309150
申请日:2019-11-04
发明人: Sara TEN HAVE
摘要: There is provided a method to synthesise peptides, a peptide being synthesised based on the amino acid sequence of a template peptide, peptides provided by the method and use of the peptides.
-
-
-
-
-
-
-
-
-